AllianceBernstein’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,650
| Closed | -$156K | – | 3261 |
|
|
2024
Q1 | $156K | Hold |
2,650
| – | – | ﹤0.01% | 2967 |
|
|
2023
Q4 | $58.7K | Sell |
2,650
-404
| -13% | -$6.09K | ﹤0.01% | 3120 |
|
|
2023
Q3 | $65.9K | Sell |
3,054
-1,346
| -31% | -$52.9K | ﹤0.01% | 3116 |
|
|
2023
Q2 | $297K | Sell |
4,400
-8,584
| -66% | -$3.55M | ﹤0.01% | 2862 |
|
|
2023
Q1 | $6.06M | Sell |
12,984
-18,566
| -59% | -$9.82M | ﹤0.01% | 1324 |
|
|
2022
Q4 | $12.6M | Buy |
31,550
+5,910
| +23% | +$2.26M | 0.01% | 987 |
|
|
2022
Q3 | $8.34M | Buy |
25,640
+20,812
| +431% | +$6.7M | ﹤0.01% | 1173 |
|
|
2022
Q2 | $1.27M | Hold |
4,828
| – | – | ﹤0.01% | 2208 |
|
|
2022
Q1 | $1.45M | Buy |
4,828
+300
| +7% | +$105K | ﹤0.01% | 2269 |
|
|
2021
Q4 | $1.6M | Sell |
4,528
-392
| -8% | -$122K | ﹤0.01% | 2264 |
|
|
2021
Q3 | $1.26M | Hold |
4,920
| – | – | ﹤0.01% | 2413 |
|
|
2021
Q2 | $3.27M | Hold |
4,920
| – | – | ﹤0.01% | 1880 |
|
|
2021
Q1 | $4.27M | Buy |
4,920
+32
| +0.7% | +$34.1K | ﹤0.01% | 1650 |
|
|
2020
Q4 | $4.53M | Sell |
4,888
-4,000
| -45% | -$4.2M | ﹤0.01% | 1538 |
|
|
2020
Q3 | $9.14M | Buy |
8,888
+900
| +11% | +$968K | ﹤0.01% | 1075 |
|
|
2020
Q2 | $8.09M | Buy |
7,988
+1,276
| +19% | +$1.18M | ﹤0.01% | 1094 |
|
|
2020
Q1 | $5.83M | Buy |
6,712
+2,060
| +44% | +$2.05M | ﹤0.01% | 1113 |
|
|
2019
Q4 | $4.99M | Buy |
4,652
+16
| +0.3% | +$16.3K | ﹤0.01% | 1428 |
|
|
2019
Q3 | $4.29M | Buy |
4,636
+36
| +0.8% | +$39.5K | ﹤0.01% | 1490 |
|
|
2019
Q2 | $5.2M | Buy |
4,600
+312
| +7% | +$341K | ﹤0.01% | 1393 |
|
|
2019
Q1 | $5.83M | Buy |
4,288
+36
| +0.8% | +$48.8K | ﹤0.01% | 1293 |
|
|
2018
Q4 | $4.92M | Buy |
4,252
+24
| +0.6% | +$27K | ﹤0.01% | 1308 |
|
|
2018
Q3 | $6.42M | Hold |
4,228
| – | – | ﹤0.01% | 1151 |
|
|
2018
Q2 | $6.62M | Sell |
4,228
-1,925
| -31% | -$2.51M | ﹤0.01% | 1116 |
|
|
2018
Q1 | $7.11M | Buy |
6,153
+351
| +6% | +$462K | 0.01% | 1051 |
|
|
2017
Q4 | $6.88M | Hold |
5,802
| – | – | ﹤0.01% | 1070 |
|
|
2017
Q3 | $7.8M | Sell |
5,802
-22
| -0.4% | -$23.2K | 0.01% | 1024 |
|
|
2017
Q2 | $4.7M | Sell |
5,824
-224
| -4% | -$156K | ﹤0.01% | 1248 |
|
|
2017
Q1 | $3.73M | Buy |
6,048
+698
| +13% | +$425K | ﹤0.01% | 1367 |
|
|
2016
Q4 | $2.86M | Sell |
5,350
-692
| -11% | -$346K | ﹤0.01% | 1578 |
|
|
2016
Q3 | $3.13M | Buy |
6,042
+1,515
| +33% | +$714K | ﹤0.01% | 1436 |
|
|
2016
Q2 | $1.86M | Buy |
4,527
+1,049
| +30% | +$480K | ﹤0.01% | 1781 |
|
|
2016
Q1 | $1.85M | Buy |
3,478
+395
| +13% | +$197K | ﹤0.01% | 1683 |
|
|
2015
Q4 | $2.35M | Buy |
3,083
+15
| +0.5% | +$9.95K | ﹤0.01% | 1485 |
|
|
2015
Q3 | $1.68M | Buy |
3,068
+120
| +4% | +$72.7K | ﹤0.01% | 1790 |
|
|
2015
Q2 | $1.73M | Buy |
2,948
+2,540
| +623% | +$1.48M | ﹤0.01% | 1921 |
|
|
2015
Q1 | $320K | Buy |
+408
| New | +$316K | ﹤0.01% | 2654 |
|
Other funds holding KYNB
AC
6CM
GCP
AllianceBernstein's KYNB Position: Q2 2024 in Review
AllianceBernstein sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 2,650 shares — an estimated $156K sold.
AllianceBernstein first reported a position in KYNB in Q1 2015 and held it in 37 quarters. The position peaked at $12.6M in Q4 2022. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.
- AllianceBernstein reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
- AllianceBernstein sold 2,650 Kyntra Bio shares in Q2 2024, an estimated $156K.
- AllianceBernstein first reported a position in Kyntra Bio in Q1 2015 and held it in 37 quarters.
- AllianceBernstein's Kyntra Bio position peaked at $12.6M in Q4 2022.
- 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.
Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.